Falb Dean 4/A
4/A · LogicBio Therapeutics, Inc. · Filed Oct 24, 2018
Insider Transaction Report
Form 4/AAmended
Falb Dean
Chief Scientific Officer
Transactions
- Award
Employee Stock Option (right to buy)
2018-10-18+30,000→ 30,000 totalExercise: $10.00Exp: 2028-10-17→ Common Stock (30,000 underlying)
Footnotes (2)
- [F1]The option becomes exercisable in equal one forty-eighth installments from the vesting commencement date, October 18, 2018.
- [F2]The Form 4, as originally filed, incorrectly reported the number of derivative securities acquired, the amount of underlying securities and the number of derivative securities beneficially owned. The Form 4, as amended by this Form 4/A, correctly reports such information.